Clinical applications of C18 and C20 chain length polyunsaturated fatty acids and their biotechnological production in plants

JAOCS, Journal of the American Oil Chemists' Society

Volumn 83, Issue 3, 2006, Pages 171-185

  Griffiths, G ^a   Morse, N ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b Efamol Canada Inc   (Canada)

Author keywords

linolenic acid; Bioengineering of oil seeds; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oils; Polyun saturated fatty acids (PUFA); PUFA and human health; Triacylglycerol biosynthesis

Indexed keywords

BIOTECHNOLOGY; BRAIN; DRUG PRODUCTS; INSULIN; MEDICAL APPLICATIONS; NUTRITION;

BIOENGINEERING OF OIL SEEDS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; FISH OILS; POLYUN-SATURATED FATTY ACIDS (PUFA); TRIACYLGLYCEROL BIOSYNTHESIS;

FATTY ACIDS;

EID: 33646248120     PISSN: 0003021X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11746-006-1191-1     Document Type: Review

References (134)

1. Brown, A.J., S. Jupe, and C.P. Briscoe, A Family of Fatty Acid Binding Receptors, DNA Cell Biol. 24:54-61 (2005).
2. Li, Y., M. Choi, G. Cavey, J. Daugherty, K. Suino, A. Kovach, N.C. Bingham, S.A. Kliewer, and H.E. Xu, Crystallographic Identification and Functional Characterization of Phospholipids as Ligands for the Orphan Nuclear Receptor Steroidogenic Factor- 1, Mol. Cell 77:491-502 (2005).
3. Sampath, H., and J.M. Ntambi, Polyunsaturated Fatty Acid Regulation of Gene Expression, Nutr. Rev. 62:333-339 (2004).
4. Ostlund, R.E., Phytosterols in Human Nutrition, Annu. Rev. Nutr. 22:533-549 (2002).
5. Norlen, L., and A. Al-Amoudi, Stratum Corneum Keratin Structure, Function and Formation: The Cubic Rod-Packing and Membrane Templating Model, J. Invest. Dermatol. 123:115-732 (2004).
6. de Jager, M.W., G.S. Gooris, I.P. Dolbnya, W. Bras, M. Ponec, and J.A. Bouwstra, Novel Mixtures Based on Synthetic Ceramides Reproduce the Unique Stratum Corneum Lipid Organization, J. Lipid Res. 45:923-932 (2004).
7. Plat, J., and R.P. Mensink, Food Components and Immune Function, Curr. Opin. Lipidol. 76:31-37 (2005).
8. FitzGerald, G.A., Prostaglandins - Modulators of Inflammation and Cardiovascular Risk, J. Clin. Rheum. 10:12-17 (2004).
9. Francois, H., and T.M. Coffman, Prostanoids and Blood Pressure: Which Way Is Up? J. Clin. Invest. 114:757-759 (2004).
10. Horrobin, D.F., Gamma Linolenic Acid, Rev. Contemp. Pharmacother. 1:1-41 (1990).
11. Mensink, R.P., Metabolic and Health Effects of Isomeric Fatty Acids, Curr. Opin. Lipidol. 16:27-30 (2005).
12. Stender, S., and J. Dyerberg, Influence of trans Fatty Acids on Health, Ann. Nutr. Metab. 48:61-66 (2004).
13. Tapiero, H., G. Ba, P. Couvreur, and K.D. Tew, Polyunsaturated Fatty Acids (PUFA) and Eicosanoids in Human Health and Pathologies, Biomed. Pharmacother. 56:215-222 (2002).
14. Horrobin, D.F., Medical Roles of Metabolites of Precursor EFAs, INFORM 6:428-435 (1995).
15. Nakamura, M.T., and T.Y. Nara, Structure, Junction and Dietary Regulation of Δ6, Δ5, and Δ9 Desaturases, Annu. Rev. Nutr. 24:345-376 (2004).
16. Manku, M.S., D.F. Horrobin, N. Morse, V. Kyte, K. Jenkins, S. Wright, and J.L. Burton, Reduced Levels of Prostaglandin Precursors in the Blood of Atopic Patients: Defective Delta-6-de-saturase Function as a Biochemical Basis for Atopy, Prostaglandins Leukot. Med. 9:615-628 (1982).
17. Horrobin, D.F., and H.A. Carmichael, Essential Fatty Acids in Relation to Diabetes, in Treatment of Diabetic Neuropathy: A New Approach, edited by D.F. Horrobin, Churchill Living-stone, London, 1992, pp. 21-39.
18. Horrobin, D.F., and M.S. Manku, Premenstrual Syndrome and Premenstrual Breast Pain (cyclical mastalgia): Disorders of Essential Fatty Acid (EFA) Metabolism, Prostaglandins Leukot. Essent. Fatty Acids 37:255-261 (1989).
19. Brush, M.G., J.S. Watson, D.F. Horrobin, and M.S. Manku, Abnormal Essential Fatty Acid Levels in Plasma of Women with Premenstrual Syndrome, Am. J. Obstet. Gynecol. 10:363-366.
20. Cunnane, S.C., S.Y. Ho, P. Dore-Duffy, K.R. Ells, and D.F. Horrobin, Essential Fatty Acid and Lipid Profiles in Plasma and Erythrocytes in Patients with Multiple Sclerosis, Am. J. Clin. Nutr. 50:801-806.
21. Navarro, E., M. Esteve, A. Olive, J. Klaassen, E. Cabre, X. Tena, F. Fernandez-Banares, C. Pastor, and M.A. Gassull, Abnormal Fatty Acid Pattern in Rheumatoid Arthritis. A Rationale for Treatment with Marine and Botanical Lipids, J. Rheumatol. 27:298-303 (2000).
22. Bell, J.G., J.R. Sargent, D.R. Tocher, and J.R. Dick, Red Blood Cell Fatty Acid Compositions in a Patient with Autistic Spectrum Disorder: A Characteristic Abnormality in Neurodevelopmental Disorders? Prostaglandins Leukot. Essent. Fatty Acids 63:21-25 (2000).
23. Manku, M.S., D.F. Horrobin, N.L. Morse, S. Wright, and J.L. Burton, Essential Fatty Acids in the Plasma Phospholipids of Patients with Atopic Eczema, Br. J. Dermatol. 110:643-648 (1984).
24. Strannegard, I.L., L. Svennerholm, and O. Strannegard, Essential Fatty Acids in Serum Lecithin of Children with Atopic Dermatitis and in Umbilical Cord Serum of Infants with High or Low IgE Levels, Int. Arch. Allergy Appl. Immunol. 82:422-423 (1987).
25. Horrobin, D.F., Essential Fatty Acid Metabolism and Its Modification in Atopic Eczema, Am. J. Clin. Nutr. 71(suppl.):367S-372S (2000).
26. Cheung, K.L., Management of Cyclical Mastalgia in Oriental Women: Pioneer Experience of Using Gamolenic Acid (Efamast) in Asia, Aust. N. Z. J. Surg. 69:492-494 (1999).
27. Belch, J.J., and A. Muir, n-6 and n-3 Essential Fatty Acids in Rheumatoid Arthritis and Other Rheumatic Conditions, Proc. Nutr. Soc. 57:563-569 (1998).
28. Belch, J.J., and A. Hill, Evening Primrose Oil and Borage Oil and Rheumatologic Conditions, Am. J. Clin. Nutr. 71(1Suppl):352S-356S (2000).
29. Kruger, M.C., and D.F. Horrobin, Calcium Metabolism, Osteoporosis and Essential Fatty Acids: A Review, Prog. Lipid Res. 36:131-151 (1997).
30. Horrobin, D.F., Interactions Between n-3 and n-6 Essential Fatty Acids (EFAs) in the Regulation of Cardiovascular Disorders and Inflammation, Prostaglandins Leukot. Essent. Fatty Acids 44:127-131(1991).
31. Horrobin, D.F., Omega-6 and Omega-3 Essential Fatty Acids in Atherosclerosis, Semin. Thromb. Hemost. 79:129-137 (1993).
32. Bucher, H.C., P. Hengstler, C. Schindler, and G. Meier, n-3 Polyunsaturated Fatty Acids in Coronary Heart Disease: A Meta-analysis of Randomized Controlled Trials, Am. J. Med. 112:298-304(2002).
33. Laidlaw, M., and B.J. Holub, Effects of Supplementation with Fish Oil-Derived n-3 Fatty Acids and γy-Linolenic Acid on Circulating Plasma Lipids and Fatty Acid Profiles in Women, Am. J. Clin. Nutr. 77:37-42.
34. Belch, J.J.F., I.R. Mackay, and J.W. Shaw, Forum on Angiology, Royal Society of Medicine, London, England, Nov. 23, 1992.
35. Leaf, A., M.B. Jorgensen, A.K. Jacobs, G. Cote, D.A. Schoen-feld, J. Scheer, B.H. Weiner, J.D. Slack, M.A. Kellett, A.E. Raizner, et al., Do Fish Oils Prevent Restenosis After Coronary Angioplasty? Circulation 90:2248-2257 (1994).
36. Bewles, M.H., D. Klonis, T.G. Plavac, B. Gonzales, D.A. Francisco, R.W. Roberts, G.R. Boxberger, L.R. Poliner, and J.P. Galichia, EPA in the Prevention of Restenosis Post PICA, Angiology 42:187-194.
37. Horrobin, D.F., Essential Fatty Acids in the Management of Impaired Nerve Function in Diabetes, Diabetes 46:S90-S93 (1997).
38. Cameron, N.E., M.A. Cotter, D.F. Horrobin, and H.J. Tritschler, Effects of α-Lipoic Acid on Neurovascular Function in Diabetic Rats: Interaction with Essential Fatty Acids, Diabetologia 41:390-399 (1998).
39. Hounsom, L., D.F. Horrobin, H. Tritschler, R. Corder, and D.R. Tomlinson, A Lipoic Acid-Gamma Linolenic Acid Conjugate Is Effective Against Multiple Indices of Experimental Diabetic Neuropathy, Diabetologia Ibid. 47:839-843 (1998).
40. Cameron, N.E., and M.A. Cotter, Comparison of the Effects of Ascorbyl Gamma-Linolenic Acid and Gamma-Linolenic Acid in the Correction of Neurovascular Deficits in Diabetic Rats, Diabetologia Ibid. 39:1047-1054(1996).
41. Holman, R.T., S.B. Johnson, and E. Kokmen, Deficiencies of Polyunsaturated Fatty Acids and Replacement by Nonessential Fatty Acids in Plasma Lipids in Multiple Sclerosis, Proc. Nail. Acad. Sci. USA 86:4720-4724 (1989).
42. Johnson, S., The Possible Role of Gradual Accumulation of Copper, Cadmium, Lead and Iron and Gradual Depletion of Zinc, Magnesium, Selenium, Vitamin B2, B6, D and E and Essential Fatty Acids in Multiple Sclerosis, Med. Hypotheses 55:239-241 (2000).
43. Field, E., and G. Joyce, Multiple Sclerosis: Effect of Gamma-Linolenate Administration upon Membranes and the Need for Extended Clinical Trials of Unsaturated Fatty Acids, Eur. Neurol. 22:78-83 (1983).
44. Nordvik, I., K.M. Myhr, H. Nyland, and K.S. Bjerve, Effect of Dietary Advice and n-3 Supplementation in Newly Diagnosed MS Patients, Acta Neural. Scand. 102:143-149 (2000).
45. 12: Mechanism of Action and Clinical Importance: Roles of the Locus Coeruleus and Central Noradrenergic Systems, Med. Hypotheses 59:594-602 (2002).
46. Horrobin, D.F., A New Category of Psychotropic Drugs: Neuroactive Lipids As Exemplified by Ethyl Eicosapentaenoate (E-E), Prog. Drug Res. 59:171-199 (2002).
47. Puri, B.K., G.M. Bydder, S.J. Counsell, B.J. Coridan, A.J. Richardson, J.V. Hajnal, C. Appel, H.M. McKee, K.S. Vaddadi, and D.F. Horrobin, MRI and Neuropsychological Improvement in Huntington Disease Following Ethyl-EPA Treatment, Neuroreport 13:123-126 (2002).
48. Richardson, A.J., and B.K. Puri, A Randomized Double-Blind, Placebo-Controlled Study of the Effects of Supplementation with Highly Unsaturated Fatty Acids on ADHD-Related Symptoms in Children with Specific Learning Difficulties, Prog. Neuropsychopharmacol. Biol. Psychiatry 26:233-239 (2002).
49. Morris, M.C., D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, R.S.Wilson, N. Aggarwal, and J. Schneider, Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease, Arch. Neural. 60:940-946 (2003).
50. Richardson, A.J., and M.A. Ross, Fatty Acid Metabolism in Neurodevelopmental Disorders: A New Perspective on Associ ations Between Attention-Deficit/Hyperactivity Disorder, Dyslexia, Dyspraxia and the Autistic Spectrum, Prostaglandins Leukot. Essent. Fatty Acids 63:1-9 (2000).
51. Rose, D.P., and J.M. Connolly, Omega-3 Fatty Acids as Cancer Chemopreventive Agents, Pharmacol. Ther. 83:211-244 (1999).
52. Munoz, S.E., M. Piegari, C.A. Guzman, and A.R. Eynard, Differential Effects of Dietary Oenothera, Zizyphus mistol and Corn Oils, and Essential Fatty Acid Deficiency on the Progression of a Murine Mammary Gland Adenocarcinoma, Nutrition 15:208-212(1999).
53. Burns, C.P., and B.A. Wagner, Effects of Exogenous Lipids on Cancer and Cancer Chemotherapy. Implications for Treatment, Drug Saf. 8:57-68(1993).
54. Wynter, M.P., S.T. Russell, and M.J. Tisdale, Effect of n-3 Fatty Acids on the Antitumour Effects of Cytotoxic Drugs, In Vivo 18:543-541 (2004).
55. Ding, W.Q., J.L. Vaught, H. Yamauchi, and S.E. Lind, Differential Sensitivity of Cancer Cells to Docosahexaenoic Acid-Induced Cytotoxicity: The Potential Importance of Down-regulation of Superoxide Dismutase 1 Expression, Mol. Cancer Ther. 3:1109-1117 (2004).
56. Heller, A.R., T. Rossel, B. Gottschlich, M. Menschikowski, R.J. Litz, T. Zimmermann, and T. Koch, Omega-3 Fatty Acids Improve Liver and Pancreas Function in Postoperative Cancer Patients, Int. J. Cancer 111:611-616 (2004).
57. Bougnoux, P., V. Chajes, E. Germain, B. Hubert, C. Lhuillery, O. Le Floch, G. Body, and G. Calais, Cytotoxic Drugs Efficacy Correlates with Adipose Tissue Docosahexaenoic Acid Level in Locally Advanced Breast Carcinoma, Br. J. Cancer 79:1765-1769 (1999).
58. Hardman, W.E., M.P. Moyer, and I.L. Cameron, Fish Oil Supplementation Enhanced CPT-11 (irinotecan) Efficacy Against MCF7 Breast Carcinoma Xenografts and Ameliorated Intestinal Side-Effects, Br. J. Cancer Ibid. 81:440-448 (1999).
59. Kenny, F.S., S.E. Pinder, I.O. Ellis, J.M. Gee, R.I. Nicholson, R.P. Bryce, and J.F. Robertson, Gamma Linolenic Acid with Tamoxifen as Primary Therapy in Breast Cancer, Int. J. Cancer 85:643-648 (2000).
60. Menendez, J.A., S. Ropero, M.M. del Barbacid, S. Montera, M. Solanas, E. Escrich, H. Cortes-Funes, and R. Colomer, Synergistic Interaction Between Vinorelbine and Gamma-Linolenic Acid in Breast Cancer Cells, Breast Cancer Res. Treat. 72:203-219 (2002).
61. Lane, J., R.E. Mansel, and W.G. Jiang, Expression of Human Delta-6-Desaturase Is Associated with Aggressiveness of Human Breast Cancer, Int. J. Mol. Med. 12:253-257 (2003).
62. Hopewell, J.W., M.E. Robbins, G.J. Van Den Aardweg, G.M. Morris, G.A. Ross, E. Whitehouse, D.F. Horrobin, and C.A. Scott, The Modulation of Radiation-Induced Damage to Pig Skin by Essential Fatty Acids, Br. J. Cancer 68:1-7 (1993).
63. Hopewell, J.W., G.J. Van Den Aardweg, G.M. Morris, M. Rezvani, M.E. Robbins, G.A. Ross, E.M. Whitehouse, C.A. Scott, and D.F. Horrobin, Amelioration of Both Early and Late Radiation-Induced Damage to Pig Skin by Essential Fatty Acids, Int. J. Radiat. Oncol. Biol. Phys. 30:1119-1125 (1994).
64. Rahbeeni, F., A.A. Hendrikse, C.M. Smuts, W.C. Gelderblom, S. Abel, and G.H. Blekkenhorst, The Effect of Evening Primrose Oil on the Radiation Response and Blood Flow of Mouse Normal and Tumour Tissues, Int. J. Radiat. Biol. 76:871-877 (2000).
65. Sims, E.C., and P.N. Plowman, Stereotactic Radiosurgery XII. Large AVM and the Failure of the Radiation Response Modifier Gamma Linolenic Acid to Improve the Therapeutic Ratio, Br. J. Neurosurg. 75:28-34 (2001).
66. Tisdale, M.J., Wasting in Cancer, J. Nutr. 129:243S-246S (1999).
67. Barber, M.D., Cancer Cachexia and Its Treatment with Fish-Oil-Enriched Nutritional Supplementation, Nutrition 17:751-755 (2001).
68. Barber, M.D., and K.C.H. Fearon, Tolerance and Incorporation of a High-Dose Eicosapentaenoic Acid Diester Emulsion by Patients with Pancreatic Cancer Cachexia, Lipids 36:347-351 (2001).
69. Bakshi, A., D. Mukherjee, A. Bakshi, A.K. Banerji, and U.M. Das, Gamma-Linolenic Acid Therapy of Human Gliomas, Nutrition 79:305-309 (2003).
70. Harris, N.M., W.R. Anderson, B.A. Lwaleed, A.J. Cooper, B.R. Birch, and L.Z. Solomon, Epirubicin and Meglumine Gamma-Linolenic Acid: A Logical Choice of Combination Therapy for Patients with Superficial Bladder Carcinoma, Cancer 97:71-78 (2003).
71. DeAntueno, R., M. Elliot, G. Ells, P. Quiroga, K. Jenkins, and D. Horrobin, In vivo and in vitro Biotransformation of the Lithium Salt of Gamma-Linolenic Acid by Three Human Carcinomas, Br. J. Cancer 75:1812-1818 (1997).
72. Johnson, C.D., M. Puntis, N. Davidson, S. Todd, and R. Bryce, Randomized Dose-Finding Phase III Study of Lithium Gamolenate in Patients with Advanced Pancreatic Adenocarcinoma, fir. J. Surg. 88:662-668 (2001).
73. DeAntueno, R., M. Bai, and M. Elliot, Tissue Distribution and Metabolism of γ-Linolenoyl-3-eicosapentaenoyl Propane Diol Enterally or Intravenously Administered to Mice Bearing Human Pancreatic Carcinomas, Anticancer Res. 79:2041-2048 (1999).
74. Horrobin, D.F., A Low Toxicity Maintenance Regime, Using Eicosapentaenoic Acid and Readily Available Drugs, for Mantle Cell Lymphoma and Other Malignancies with Excess Cyclin Dl Levels, Med. Hypotheses 60:615-623 (2003).
75. Horrocks, L.A., and Y.K. Yeo, Health Benefits of Docosahexaenoic Acid (DHA), Pharmacol. Res. 40:111-225 (1999).
76. Innis, S.M., The Role of Dietary n-6 and n-3 Fatty Acids in the Developing Brain, Dev. Neurosci. 22:474-480 (2000).
77. Voigt, R.G., C.L. Jensen, J.K. Fraley, J.C. Rozelle, F.R. Brown, and W.C. Heird, Relationship Between Omega 3 Long-Chain Polyunsaturated Fatty Acid Status During Early Infancy and Neurodevelopmental Status at 1 Year of Age, J. Hum. Nutr. Diet. 75:111-120 (2002).
78. Infante, J.P., and V.A. Huszagh, Impaired Arachidonic Acid (20:4n-6) and Docosahexaenoic Acid (22:6n-3) Synthesis by Phenylalanine Metabolites as Etiological Factors in the Neuropathology of Phenylketonuria, Mol. Gen. Metab. 72:185-198 (2001).
79. Lands, W.E.M., Diet Could Prevent Many Diseases, Lipids 35:317-321 (2003).
80. Fox, H., L. Whally, K. Wahle, and I. Deary, Omega-3 Fatty Acids Are Associated with Cognitive Aging, Proceedingss of the 1st Annual Brain Lipid Conference, Aviemore, Scotland, September 2003.
81. Horrocks, L.A., and A.A. Farooqui, Docosahexaenoic Acid in the Diet: Its Importance in Maintenance and Restoration of Neural Membrane Function, Prostaglandins Leukot. Essent. Fatty Acids 70:361-372 (2004).
82. Sattar, N., C. Berry, and I.A. Greer, Essential Fatty Acids in Relation to Pregnancy Complications and Fetal Development, Br. J. Obstet. Gynaecol. 105:1248-1255 (1998).
83. Hornstra, G., Essential Fatty Acids in Mothers and Their Neonates, Am. J. Clin. Nutr. 71(Suppl.):126S-129S (2000).
84. Crawford, M., Placental Delivery of Arachidonic Acid and Docosahexaenoic Acids: Implications for the Lipid Nutrition of Premature Infants, Am. J. Clin. Nutr. Ibid. 71:275S-284S (2000).
85. Helland, I.B., L. Smith, K. Saarem, O.D. Saugstad, and C.A. Drevon, Maternal Supplementation with Very-Long-Chain n-3 Fatty Acids During Pregnancy and Lactation Augments Children's IQ at 4 Years of Age, Pediatrics 111:e39-e44 (2003).
86. Forsyth, J.S., P. Willatts, C. Agostoni, J. Bissenden, P. Casaer, and G. Boehm, Long Chain Polyunsaturated Fatty Acid Supplementation in Infant Formula and Blood Pressure in Later Childhood: Follow Up of a Randomised Controlled Trial, Br. Med. J. 326:953 (2003).
87. Das, U.N., The Lipids That Matter from Infant Nutrition to Insulin Resistance, Prostaglandins Leukot. Essent. Fatty Acids 67:1-12 (2002).
88. Makrides, M., M. Neumann, K. Simmer, J. Pater, and R. Gibson, Are Long Chain Polyunsaturated Fatty Acids Essential Nutrients in Infancy? Lancet 345:1463-1468 (1995).
89. Makrides, M., and R.A. Gibson, Long-Chain Polyunsaturated Fatty Acid Requirements During Pregnancy and Lactation, Am. J. Clin. Nutr. 71:3078-31 IS (2000).
90. Hibbeln, J.R., Seafood Consumption, the DHA Content of Mothers' Milk and Prevalence Rates of Postpartum Depression: A Cross-National Ecological Analysis, J. Affect. Disord. 69:15-19 (2002).
91. Otto, S.J., R.H.M. de Groot, and G. Hornstra, Increased Risk of Postpartum Depressive Symptoms Is Associated with Slower Normalization After Pregnancy of the Functional Docosahexaenoic Acid Status, Prostaglandins Leukot. Essent. Fatty Acids 69:237-243 (2003).
92. Innis, S.M., and S.L. Elias, Intakes of Essential n-6 and n-3 Polyunsaturated Fatty Acids Among Pregnant Canadian Women, Am. J. Clin. Nutr. 77:473-478 (2003).
93. Stobart, A.K., and G. Griffiths, Fatty Acid Biosynthesis and Triacylglycerol Assembly, in Handbook of Food Enzymology, edited by J.R. Whitaker, A.G.J. Voragen, and D.W.S. Wong, Marcel Dekker, New York, 2002, pp. 125-145.
94. Das, S., T.J. Roscoe, M. Delseny, P.S. Srivastava, and M. Lakshmikumaran, Cloning and Molecular Characterization of the Fatty Acid Elongase 1 (FAE 1) Gene from High and Low Erucic Acid Lines of Brassica campestris and Brassica oleracea, Plant Sci. 162:245-250 (2002).
95. Lee, Y.K., Microalgal Mass Culture Systems and Methods: Their Limitation and Potential, J. Appl. Phycol. 13:307-315 (2001).
96. Yokoo, E.M., J.G. Valente, L. Grattan, S.L. Schmidt, I. Platt, and E.K. Silbergeld, Low Level Methylmercury Exposure Affects Neuropsychological Function in Adults, Environmental Health: A Global Access Science Source 2, 1-11 (http://www.ehjournal.nct/content/2/1/8) (accessed Nov. 2003).
97. Drexler, H., P. Spiekermann, A. Meyer, F. Domergue, T. Zank, P. Sperling, A. Abbadi, and E. Heinz, Metabolic Engineering of Fatty Acids for Breeding of New Oilseed Crops: Strategies, Problems and First Results, J. Plant Physiol. 76:779-802 (2003).
98. Griffiths, G., A.K. Stobart, and S. Stymne, The Acylation of sn-Glycerol 3-Phosphate and the Metabolism of Phosphatidate in Microsomal Preparations from the Developing Cotyledons of Safflower Seed, Biochem. J. 230:379-388 (1985).
99. Ichihara, K., T. Asahi, and S. Fujii, 1-Acyl-sn-glycerol-3-phosphate Acytransferase in Maturing Safflower Seeds and Its Contribution to the Non-random Fatty Acid Distribution of Triacylglycerol, Eur. J. Biochem. 767:339-347 (1987).
100. Griffiths, G., A.K. Stobart, and S. Stymne, Δ6 and Δ12 Desaturase Activities and Phosphatidic Acid Formation in Microsomal Preparations from the Developing Cotyledons of Common Borage, Biochem. J. 252:641-647 (1988).
101. Frentzen, M., and P.P. Wolter, Molecular Biology of Acytransferases Involved in Glycerolipid Synthesis, in Plant Lipid Biosynthesis, edited by J.L. Harwood, Society for Experimental Biology Seminar Series 67, Cambridge University Press, Cambridge, 1998, pp. 247-272.
102. Ichihara, K., N. Murata, and S. Fujii, Intracellular Translocation of Phosphatidate Phosphatase in Maturing Safflower Seeds: A Possible Mechanism of Feedforward Control of Triacylglycerol Biosynthesis for Fatty Acids, Biochim. Biophys. Acta 1043:221-234 (1990).
103. Lardizabal, K.D., J.T. Mai, N.W. Wagner, A. Wyrick, T. Voelker, and D.J. Hawkins, DGAT2 Is a New Diacylglycerol Acyltransferase Gene Family - Purification, Cloning and Expression in Insect Cells of Two Polypeptides from Mortierella ramanniana with Diacylglycerol Acyltransferase Activity, J. Biol, Chem. 276:38862-38869 (2001).
104. Jako, C., A. Kumar, Y.D. Wei, J.T. Zou, D.L. Barton, E.M. Giblin, P.S. Covello, and D.C. Taylor, Seed-specific Over-expression of an Arabidopsis cDNA Encoding a Diacylglycerol Acyltransferase Enhances Seed Oil Content and Seed Weight, Plant Physiol. 726:861-874 (2001).
105. Stymne, S., and A.K. Stobart, Evidence for the Reversibility of the Acyl-CoA:Lysophosphatidylcholine Acyltransferase in Microsomal Preparations from Developing Safflower Cotyledons and Rat Liver, Biochem. J. 225:305-314 (1984).
106. Stobart, S., and S. Stymne, Interconversion of Diacylglycerol and Phosphatidylcholine During Triacylglycerol Production in Microsomal Preparations of Developing Cotyledons of Safflower, Biochem. J. Ibid. 252:217-221 (1985).
107. Stobart, A.K., M. Mancha, M. Lenman, A. Dahlqvist, and S. Stymne, Triacylglycerols Are Synthesised and Utilized by Transacylation Reactions in Microsomal Preparations of Developing Safflower (Carthamus tinctorius L.) Seeds, Planta 205:58-66 (1997).
108. Tumaney, A.W., S. Shekar, and R. Rajasekharan, Identification, Purification and Characterization of Monoacylglycerol Acyltransferase from Developing Peanut Cotyledons, J. Biol. Chem. 276:10847-10852 (2001).
109. Cheng, D., T.C. Nelson, J. Chen, S.G. Walker, J. Wardwell-Swanson, R. Meegalla, R. Taub, J.T. Billheimer, M. Ramaker, and J. N. Feder, Identification of Acyl Coenzyme A:Monoacylglycerol Acyltransferase 3, an Intestinal Specific Enzyme Implicated in Dietary Fat Absorption, J. Biol. Chem. Ibid. 278:13611-13614 (2003).
110. Lee, D.P., A.S. Deonarine, M. Kienetz, Q.S. Zhu, M. Skrzypczak, M. Chan, and P.C. Choy, A Novel Pathway for Lipid Biosynthesis: The Direct Acylation of Glycerol, J. Lipid Res. 42:1979-1986 (2001).
111. Dahlquist, A., U. Stahl, M. Lenman, A. Banas, M. Lee, L. Sandager, H. Ronne, and S. Stymne, Phospholipid:Diacylglycerol Acyltransferase: An Enzyme That Catalyzes the AcylCoA-Independent Formation of Triacylglycerol in Yeast and Plants, Proc. Natl. Acad. Sci. USA 97:6487-6492 (2000).
112. Stahl, U., A.S. Carlsson, M. Lenman, A. Dahlqvist, B.Q. Huang, W. Banas, A. Banas, and S. Stymne, Cloning and Functional Characterization of a Phospholipid:Diacylglycerol Acyltransferase from Arabidopsis, Plant Phvsiol. 135:1324-1335 (2004).
113. 9 Polyunsaturated Fatty Acid-Specific Elongating Activity from the Docosahexaenoic Acid (DHA)-Producing Microalga, Isochrysis galbana, FEBS Lett. 510:159-165 (2002).
114. 9 Polyunsaturated Fatty Acid Specific Elongase Component Alters Arabidopsis Glycerolipid Profiles, Plant Physiol. 135: 859-866 (2004).
115. 5 Domain Results in the Accumulation of High Levels of Δ6-Desaturated Fatty Acids in Transgenic Tobacco, Proc. Natl. Acad. Sci. USA 94:4211-4216 (1997).
116. 6 Desaturase. J. Biol. Chem. 274:471-477 (1999).
117. 6-Fatty Acid-Desaturase by Heterologous Expression in Saccharomyces cerevisiae, Biochem. J. 330:611-614 (1998).
118. 6-Acyl-Group Desaturase by Targeted Gene Disruption in Physcomitrella patens, Plant J. 75:39-48 (1998).
119. Huang, Y.S., S. Chaudhary, J.M. Thurmond, E.G. Bobik Jr., L. Yuan, G.M. Chan, S.J. Kirchner, P. Mukerji, and D.S. Knutzon, Cloning of Δ12- and Δ6-Desaturases from Mortierella alpina and Recombinant Production of γ-Linolenic Acid in Saccharomyces cerevisiae, Lipids 24:649-659 (1999).
120. Sakuradani, E., M. Kobayashi, and S. Shimizu, Δ6-Fatty Acid Desaturase from an Arachidonic Acid-Producing Mortierella Fungus. Gene Cloning and Its Heterologous Expression in a Fungus, Aspergillus, Gene 238:445-453 (1999).
121. Beaudoin, F., L.V. Michaelson, S.J. Hey, M.J. Lewis, P.R. Shewry, O. Sayanova, and J.A. Napier, Heterologous Reconstitution in Yeast of the Polyunsaturated Fatty Acid Biosynthetic Pathway, Proc. Natl. Acad. Sci. USA 97:6421-6426 (2000).
122. Parker-Barnes, J.M., T. Das, E. Bobik, A.E. Leonard, J.M. Thurmond, L. Chuang, Y.S. Huang, and P. Mukerji, Identification and Characterization of an Enzyme Involved in the Elongation of n-6 and n-3 Polyunsaturated Fatty Acids, Proc. Natl. Acad. Sci. USA Ibid. 97:8284-8289 (2000).
123. Zank, T.K., U. Zähringer, C. Beckmann, G. Pohnert, W. Boland, H. Holtorf, R. Reski, J. Lerchl, and E. Heinz, Cloning and Functional Characterization of an Enzyme Involved in the Elongation of A6-Polyunsaturated Fatty Acids from the Moss Physcomitrella patens, Plant J. 57:255-268 (2002).
124. Cho, H.P., M.T. Nakamura, and S.D. Clarke, Cloning, Expression, and Fatty Acid Regulation of the Human A-5 Desaturase, J. Biol. Chem. 274:37335-37339 (1999).
125. Michaelson, L.V., J.A. Napier, M. Lewis, G. Griffiths, C.M. Lazarus, and A.K. Stobart, Functional Identification of a Fatty Acid Δ5-Desaturase Gene from Caenorhabditis elegans, FEBS Lett. 439:215-218 (1998).
126. Michaelson, L.V., C.M. Lazarus, G. Griffiths, J.A. Napier, and A.K. Stobart, Isolation of Δ5 Fatty Acid Desaturase Gene from Mortierella alpina, J. Biol. Chem. 273:19055-19059 (1998).
127. Watts, J.L., and J. Browse, Isolation and Characterization of a Δ5-Fatty Acid Desaturase from Caenorhabditis elegans, Arch. Biochem. Biophys. 362:175-182 (1999).
128. Wallis, J.G., and J. Browse, The Δ8 Desaturase of Euglena gracilis: An Alternate Pathway for Synthesis of 20-Carbon Polyunsaturated Fatty Acids, Arch. Biochem. Biophys. Ibid. 365:307-316 (1999).
129. Qi, B., T. Fräser, S. Mugford, G. Dobson, J. Butler, J.A. Napier, A.K. Stobart, and C.M. Lazarus, Production of Very Long Chain Polyunsaturated Omega-3 and Omega-6 Fatty Acids in Plants, Nat. Biotechnol. 22:739-745 (2004).
130. Domergue, F., A. Abbadi, C. Ott, T.K. Zank, U. Zähringer, and E. Heinz, Acyl Carriers Used as Substrates by the Desaturases and Elongases Involved in Very Long-Chain Polyunsaturated Fatty Acids Biosynthesis Reconstituted in Yeast, J. Biol. Chem. 278:35115-35126 (2003).
131. Qiu, X., H.P. Hong, and S.L. Mackenzie, Identification of a Δ4 Fatty Acid Desaturase from Thraustochytrium sp. Involved in the Biosynthesis of Docosahexanoic Acid by Heterologous Expression in Saccharomyces cerevisiae and Brassica juncea, J. Biol. Chem. Ibid. 276:31561-31566 (2001).
132. Ternes, P., S. Franke, U. Zahringer, P. Sperling, and E. Heinz, Identification and Characterization of a Sphingolipid Δ4-Desaturase Family, J. Biol. Chem. Ibid. 277:25512-25518 (2002).
133. Tonon, T., D. Harvey, T.R. Larson, and I.A. Graham, Identification of a Very Long Chain Polyunsaturated Δ4-Desaturase from the Microalga Pavlova lutheri, FEBS Lett. 555:440-444 (2003).
134. Cameron, N.E., and M.A. Cotter, Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy, Diabetes 46: 1-37 (1997).